Extracellular vesicle proteomics uncovers energy metabolism, complement system, and endoplasmic reticulum stress response dysregulation postexercise in males with myalgic encephalomyelitis/chronic fatigue syndrome

Abstract

Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating illness characterized by post-exertional malaise (PEM), a worsening of symptoms following exertion. The biological mechanisms underlying PEM remain unclear. Extracellular vesicles (EVs) play a key role in cell–cell communication and may provide insight into ME/CFS pathophysiology post-exertion. Emerging evidence suggests similarities between ME/CFS and Long COVID, including PEM and overlapping immune and metabolic dysfunctions, highlighting the need for deeper mechanistic understanding.

Methods: This study explores the EV proteome response to exercise in 10 males with ME/CFS and 12 well-matched sedentary male controls. Participants underwent a maximal cardiopulmonary exercise test, and plasma samples were collected at baseline, 15 min, and 24 h postexercise. EVs were isolated from plasma using size-exclusion chromatography and characterized with nanoparticle tracking analysis. EV protein abundance was quantified with untargeted proteomics (nanoLC-MS/MS). Comprehensive analyses included differential abundance, pathway enrichment, protein–protein interaction networks, and correlations between EV protein dynamics and clinical or exercise physiology data.

Results: ME/CFS patients exhibited many significantly altered EV proteomic responses compared with controls, including downregulation of TCA cycle-related proteins and upregulation of complement system proteins at 15 min postexercise. Changes in proteins involved in protein folding and the endoplasmic reticulum (ER) stress response during recovery were highly correlated with PEM severity, highlighting their potential as therapeutic targets. EV protein changes postexercise were also associated with disease severity and unrefreshing sleep. Correlations between EV protein levels and the exercise parameters VO₂ peak and ventilatory anaerobic threshold were observed in controls but were absent in ME/CFS patients, suggesting disrupted EV-mediated physiological processes.

Conclusions: ME/CFS patients exhibit a maladaptive EV proteomic response to exercise, characterized by metabolic impairments, immune overactivation, and ER stress response dysregulation. These findings provide insight into the molecular basis of PEM and suggest promising targets for improving recovery and energy metabolism in ME/CFS.

Keywords

chronic fatigue syndrome / complement / exercise / extracellular vesicle cargo / ME/CFS / myalgic encephalomyelitis / proteomics

References

[1] IOM IoM. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: Redefining an illness. National Academies Press; 2015.

[2] Arroll MA, Attree EA, O'Leary JM, Dancey CP. The delayed fatigue effect in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Fatigue: Biomed Health Behav. 2014; 2(2): 57-63.

[3] Chu L, Valencia IJ, Garvert DW, Montoya JG. Deconstructing post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: a patient-centered, cross-sectional survey. PloS one. 2018; 13(6): e0197811.

[4] Clauw DJ. Perspectives on fatigue from the study of chronic fatigue syndrome and related conditions. PM&R. 2010; 2(5): 414-430.

[5] Stussman B, Williams A, Snow J, et al. Characterization of post-exertional malaise in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. 2020; 11: 1025.

[6] Grach SL, Seltzer J, Chon TY. Ganesh R. Diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome. Mayo Clin Proc. 2023; 98(10): 1544-1551.

[7] Germain A, Ruppert D, Levine SM, Hanson MR. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol BioSystems. 2017; 13(2): 371-379.

[8] Mandarano AH, Maya J, Giloteaux L, et al. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. The J Clin Investigat. 2020; 130(3): 1491-1505.

[9] Maya J. Immune cell exhaustion, dysfunction, and metabolism in myalgic encephalomyelitis/chronic fatigue syndrome. Cornell University; 2023.

[10] Distefano G, Goodpaster BH. Effects of exercise and aging on skeletal muscle. Cold Spring Harbor Perspect Med. 2018; 8(3): a029785.

[11] Myers J. Exercise and cardiovascular health. Circulation. 2003; 107(1): e2-e5.

[12] Nystoriak MA, Bhatnagar A. Cardiovascular effects and benefits of exercise. Front Cardiovasc Med. 2018; 5: 135.

[13] Germain A, Giloteaux L, Moore GE, et al. Plasma metabolomics reveals disrupted response and recovery following maximal exercise in myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2022; 7(9): e157621.

[14] Glass KA, Germain A, Huang YV, Hanson MR. Urine metabolomics exposes anomalous recovery after maximal exertion in female ME/CFS patients. Int J Mol Sci. 2023; 24(4): 3685.

[15] Keller B, Receno CN, Franconi CJ, et al. Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations. J Translat Med. 2024; 22(1): 1-35.

[16] Stevens S, Snell C, Stevens J, Keller B, VanNess JM. Cardiopulmonary exercise test methodology for assessing exertion intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2018; 6: 386825.

[17] Dellar ER, Hill C, Melling GE, Carter DR, Baena-Lopez LA. Unpacking extracellular vesicles: rNA cargo loading and function. J Extracell Biol. 2022; 1(5): e40.

[18] Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019; 8(7): 727.

[19] Mir B, Goettsch C. Extracellular vesicles as delivery vehicles of specific cellular cargo. Cells. 2020; 9(7): 1601.

[20] Frühbeis C, Helmig S, Tug S, Simon P, Krämer-Albers E-M. Physical exercise induces rapid release of small extracellular vesicles into the circulation. J Extracell Vesicles. 2015; 4(1): 28239.

[21] Whitham M, Parker BL, Friedrichsen M, et al. Extracellular vesicles provide a means for tissue crosstalk during exercise. Cell Metabolism. 2018; 27(1): 237-251.

[22] Bertoldi K, Cechinel LR, Schallenberger B, et al. Circulating extracellular vesicles in the aging process: impact of aerobic exercise. Mol Cell Biochem. 2018; 440: 115-125.

[23] Nederveen JP, Warnier G, Di Carlo A, Nilsson MI, Tarnopolsky MA. Extracellular vesicles and exosomes: insights from exercise science. Front Physiol. 2021; 11: 604274.

[24] Siqueira IR, Palazzo RP, Cechinel LR. Circulating extracellular vesicles delivering beneficial cargo as key players in exercise effects. Free Radical Biol Med. 2021; 172: 273-285.

[25] Sullivan BP, Nie Y, Evans S, et al. Obesity and exercise training alter inflammatory pathway skeletal muscle small extracellular vesicle microRNAs. Experiment Physiol. 2022; 107(5): 462-475.

[26] Castro-Marrero J, Serrano-Pertierra E, Oliveira-Rodríguez M, et al. Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study. J Extracell Vesicles. 2018; 7(1): 1453730.

[27] Almenar-Pérez E, Sarría L, Nathanson L, Oltra E. Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in myalgic encephalomyelitis/chronic fatigue syndrome. Sci Rep. 2020; 10(1): 1-15.

[28] Giloteaux L, Glass KA, Germain A, Franconi CJ, Zhang S, Hanson MR. Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise. J Extracell Vesicles. 2024; 13(1): 12403.

[29] Giloteaux L, Li J, Hornig M, Lipkin WI, Ruppert D, Hanson MR. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls. J Translation Med. 2023; 21(1): 1-22.

[30] Giloteaux L, O'Neal A, Castro-Marrero J, Levine SM, Hanson MR. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study. J Translation Med. 2020; 18(1): 1-17.

[31] Eguchi A, Fukuda S, Kuratsune H, et al. Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome. Brain, Behav Immun. 2020; 84: 106-114.

[32] Valdez AR, Hancock EE, Adebayo S, et al. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front Pediatr. 2018; 6: 412.

[33] Friedberg F, Adamowicz JL, Bruckenthal P, et al. Sex differences in post-exercise fatigue and function in myalgic encephalomyelitis/chronic fatigue syndrome. Sci Rep. 2023; 13(1): 5442.

[34] Thomas N, Gurvich C, Huang K, Gooley PR, Armstrong CW. The underlying sex differences in neuroendocrine adaptations relevant to myalgic encephalomyelitis chronic fatigue syndrome. Front Neuroendocrinol. 2022; 66: 100995.

[35] Gamer J, Van Booven DJ, Zarnowski O, et al. Sex-dependent transcriptional changes in response to stress in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a pilot project. Int J Mol Sci. 2023; 24(12): 10255.

[36] Nkiliza A, Parks M, Cseresznye A, Oberlin S, Evans JE, Darcey T, et al. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms. J Translation Med. 2021; 19(1): 370.

[37] O'Neal AJ, Glass KA, Emig CJ, et al. Survey of anti-pathogen antibody levels in myalgic encephalomyelitis/chronic fatigue syndrome. Proteomes. 2022; 10(2): 21.

[38] Carruthers BM, Jain AK, De Meirleir KL, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chron Fatigue Synd. 2003; 11(1): 7-115.

[39] Ware JE. SF-36 health survey. Manual and interpretation guide. Health Institute. 1993; 6: 22. 1-6.

[40] Smets E, Garssen B, Bd Bonke, De Haes J. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosomat Res. 1995; 39(3): 315-325.

[41] Bell DS. The doctor's guide to chronic fatigue syndrome: understanding, treating, and living with CFIDS. Da Capo Press; 1994.

[42] Baraniuk JN, Adewuyi O, Merck SJ, et al. A Chronic Fatigue Syndrome (CFS) severity score based on case designation criteria. Am J Translat Res. 2013; 5(1): 53.

[43] Fu Q, Liu Z, Bhawal R, et al. Comparison of MS 2, synchronous precursor selection MS 3, and real-time search MS 3 methodologies for lung proteomes of hydrogen sulfide treated swine. Anal Bioanal Chem. 2021; 413: 419-429.

[44] Unwin RD, Griffiths JR, Whetton AD. Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS/MS. Nat Protoc. 2010; 5(9): 1574-1582.

[45] Théry C, Witwer KW, Welsh JA, et al. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. 2024.

[46] Stekhoven DJ. missForest: nonparametric missing value imputation using random forest. Astrophysics Source Code Library. 2015: 1505011. ascl.

[47] Stekhoven DJ, Bühlmann P. MissForest—non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012; 28(1): 112-118.

[48] Benjamini Y, Yekutieli D. False discovery rate-adjusted multiple confidence intervals for selected parameters. J Am Stat Assoc. 2005; 100(469): 71-81.

[49] Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statist Soc Series B (Methodological). 1995; 57(1): 289-300.

[50] Xie Z, Bailey A, Kuleshov MV, et al. Gene set knowledge discovery with Enrichr. Curr Protoc. 2021; 1(3): e90.

[51] Canzler S, Hackermuller J. multiGSEA: a GSEA-based pathway enrichment analysis for multi-omics data. BMC Bioinform. 2020; 21(1): 561.

[52] Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. biorxiv. 2016: 060012.

[53] Sales G, Calura E, Cavalieri D. Romualdi C. Graphite-a bioconductor package to convert pathway topology to gene network. BMC bioinformatics. 2012; 13: 1-12.

[54] Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucl Acids Res. 2019; 47: D607-D13. D1.

[55] Kokla M, Virtanen J, Kolehmainen M, Paananen J, Hanhineva K. Random forest-based imputation outperforms other methods for imputing LC-MS metabolomics data: a comparative study. BMC Bioinform. 2019; 20(1): 1-11.

[56] Wei R, Wang J, Su M, et al. Missing value imputation approach for mass spectrometry-based metabolomics data. Sci Rep. 2018; 8(1): 663.

[57] Keerthikumar S, Chisanga D, Ariyaratne D, et al. ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol. 2016; 428(4): 688-692.

[58] Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012; 10(12): e1001450.

[59] Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43): 15545-15550.

[60] Szabo G, Momen-Heravi F. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2017; 14(8): 455-466.

[61] Ohmichi T, Mitsuhashi M, Tatebe H, Kasai T, El-Agnaf OMA, Tokuda T. Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases. Parkinsonism Related Disorders. 2019; 61: 82-87.

[62] Chirinos JA, Heresi GA, Velasquez H, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am College Cardiol. 2005; 45(9): 1467-1471.

[63] Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000; 101(8): 841-843.

[64] Annibalini G, Contarelli S, Lucertini F, et al. Muscle and systemic molecular responses to a single flywheel based iso-inertial training session in resistance-trained men. Front Physiol. 2019; 10: 554.

[65] Lovett JA, Durcan PJ, Myburgh KH. Investigation of circulating extracellular vesicle microRNA following two consecutive bouts of muscle-damaging exercise. Front Physiol. 2018; 9: 1149.

[66] Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev. 2001; 180: 35-48.

[67] Dudkina NV, Spicer BA, Reboul CF, et al. Structure of the poly-C9 component of the complement membrane attack complex. Nat Commun. 2016; 7(1): 10588.

[68] Arntz O, van den Bosch M, Thurlings R, Vermeulen M, van der Kraan P, Van de Loo F. Protein profiling of plasma extracellular vesicles from osteoarthritic patients points to a prothrombotic state and a neuropathic component in this disease. Osteoarthr Cartilage. 2023; 31: S102.

[69] Li H-Y, Wang H-J, Du X-P, Liu J-P, Yang X-C, Zheng M-L, Plasma Exosomal Proteins Predict the Prognosis of Acute ST-segment Elevation Myocardial Infarction. 2022.

[70] Vengen IT, Enger TB, Videm V, Garred P. Pentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction-the HUNT2 study. Sci Rep. 2017; 7(1): 43045.

[71] Burgelman M, Dujardin P, Vandendriessche C, Vandenbroucke RE. Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders. Front Immunol. 2023; 13: 1055050.

[72] Karasu E, Eisenhardt SU, Harant J, Huber-Lang M. Extracellular vesicles: packages sent with complement. Front Immunol. 2018; 9: 721.

[73] Bhargava P, Nogueras-Ortiz C, Kim S, Delgado-Peraza F, Calabresi PA. Kapogiannis D. Synaptic and complement markers in extracellular vesicles in multiple sclerosis. Multiple Scler J. 2021; 27(4): 509-518.

[74] Mitaki S, Wada Y, Sheikh AM, Yamaguchi S, Nagai A. Proteomic analysis of extracellular vesicles enriched serum associated with future ischemic stroke. Sci Rep 2021; 11(1): 24024.

[75] Castro-Marrero J, Zacares M, Almenar-Pérez E, Alegre-Martin J, Oltra E. Complement component C1q as a potential diagnostic tool for myalgic encephalomyelitis/chronic fatigue syndrome subtyping. J Clin Med. 2021; 10(18): 4171.

[76] Nunes M, Vlok M, Proal A, Kell DB, Pretorius E. Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery. Cardiovasc Diabetol. 2024; 23(1): 254.

[77] Yamano E, Sugimoto M, Hirayama A, et al. Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci Rep. 2016; 6(1): 34990.

[78] McArdle A, McArdle F, Jackson M, Page S, Fahal I, Edwards R. Investigation by polymerase chain reaction of enteroviral infection in patients with chronic fatigue syndrome. Clin Sci. 1996; 90(4): 295-300.

[79] Smits B, van den Heuvel L, Knoop H, et al. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome. Mitochondrion. 2011; 11(5): 735-738.

[80] Armstrong CW, McGregor NR, Lewis DP, Butt HL, Gooley PR. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics. 2015; 11: 1626-1639.

[81] Fluge Ø, Mella O, Bruland O, et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. 2016; 1(21): e89376.

[82] Yagin FH, Alkhateeb A, Raza A, et al. An explainable artificial intelligence model proposed for the prediction of myalgic encephalomyelitis/chronic fatigue syndrome and the identification of distinctive metabolites. Diagnostics. 2023; 13(23): 3495.

[83] Holeček M. Branched-chain amino acids and branched-chain keto acids in hyperammonemic states: metabolism and as supplements. Metabolites. 2020; 10(8): 324.

[84] Suryawan A, Hawes JW, Harris RA, Shimomura Y, Jenkins AE, Hutson SM. A molecular model of human branched-chain amino acid metabolism. Am J Clin Nutr. 1998; 68(1): 72-81.

[85] Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. elife. 2016; 5: e10250.

[86] Benham AM. The protein disulfide isomerase family: key players in health and disease. Antioxidants Redox Signal. 2012; 16(8): 781-789.

[87] Brecker M, Khakhina S, Schubert TJ, Thompson Z, Rubenstein RC. The Probable, Possible, and Novel Functions of ERp29. Front Physiol. 2020; 11: 574339.

[88] Andreu CI, Woehlbier U, Torres M, Hetz C. Protein disulfide isomerases in neurodegeneration: from disease mechanisms to biomedical applications. FEBS Lett. 2012; 586(18): 2826-2834.

[89] Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003; 4(1): 49-60.

[90] Honjo Y, Kaneko S, Ito H, et al. Protein disulfide isomerase-immunopositive inclusions in patients with amyotrophic lateral sclerosis. Amyotrop Lat Sclerosis. 2011; 12(6): 444-450.

[91] Lee CH, Chiang CF, Lin FH, et al. PDIA4, a new endoplasmic reticulum stress protein, modulates insulin resistance and inflammation in skeletal muscle. Front Endocrinol (Lausanne). 2022; 13: 1053882.

[92] Su SC, Chien CY, Chen YC, et al. PDIA4, a novel ER stress chaperone, modulates adiponectin expression and inflammation in adipose tissue. Biofactors. 2022; 48(5): 1060-1075.

[93] Bu S, Singh A, Nguyen HC, et al. Protein disulfide isomerase 4 is an essential regulator of endothelial function and survival. Int J Mol Sci. 2024; 25(7): 3913.

[94] Tombran-Tink J. The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling. Front Biosci. 2005; 10(1-3): 2131.

[95] Yu J, Sane S, Kim JE, et al. Biogenesis and delivery of extracellular vesicles: harnessing the power of EVs for diagnostics and therapeutics. Front Mol Biosci. 2023; 10: 1330400.

[96] Collett GP, Redman CW, Sargent IL, Vatish M. Endoplasmic reticulum stress stimulates the release of extracellular vesicles carrying danger-associated molecular pattern (DAMP) molecules. Oncotarget. 2018; 9(6): 6707-6717.

[97] Koncz A, Turiák L, Németh K, et al. Endoplasmin is a hypoxia-inducible endoplasmic reticulum-derived cargo of extracellular vesicles released by cardiac cell lines. Membranes. 2023; 13(4): 431.

[98] Bare Y, Defourny K, Bretou M, Van Niel G, Nolte-’t Hoen E, Gaudin R. The endoplasmic reticulum as a cradle for virus and extracellular vesicle secretion. Trends Cell Biol. 2024; 35(4): 282-293.

[99] Wang PY, Ma J, Kim YC, et al. WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci USA. 2023; 120(34): e2302738120.

[100] Al-Jassar C, Bikker H, Overduin M, Chidgey M. Mechanistic basis of desmosome-targeted diseases. J Mol Biol. 2013; 425(21): 4006-4022.

[101] Dallacasagrande V, Hajjar KA. Annexin A2 in inflammation and host defense. Cells. 2020; 9(6): 1499.

[102] Lim HI, Hajjar KA. Annexin A2 in fibrinolysis, inflammation and fibrosis. IntJ MolSci. 2021; 22(13): 6836.

[103] Colombatti A, Doliana R, Bot S, et al. The EMILIN protein family. Matrix Biol. 2000; 19(4): 289-301.

[104] Litteri G, Carnevale D, D'Urso A, et al. Vascular smooth muscle Emilin-1 is a regulator of arteriolar myogenic response and blood pressure. Arterioscler, Thromb, Vascular Biol. 2012; 32(9): 2178-2184.

[105] Hoel F, Hoel A, Pettersen IK, et al. A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight. 2021; 6(16): e149217.

[106] Naviaux RK, Naviaux JC, Li K, et al. Metabolic features of chronic fatigue syndrome. Proc Nat Acad Sci. 2016; 113(37): E5472-E5480.

[107] Tomas C, Elson JL, Newton JL, Walker M. Substrate utilisation of cultured skeletal muscle cells in patients with CFS. Sci Rep. 2020; 10(1): 18232.

[108] VanNess JM, Stevens SR, Bateman L, Stiles TL, Snell CR. Postexertional malaise in women with chronic fatigue syndrome. J Women's Health. 2010; 19(2): 239-244.

[109] Darragh IAJ, O'Driscoll L, Egan B. Exercise Training and Circulating Small Extracellular Vesicles: Appraisal of Methodological Approaches and Current Knowledge. Front Physiol. 2021; 12: 738333.

[110] Karimi N, Dalirfardouei R, Dias T, Lötvall J, Lässer C. Tetraspanins distinguish separate extracellular vesicle subpopulations in human serum and plasma-Contributions of platelet extracellular vesicles in plasma samples. J Extracell Vesicles. 2022; 11(5): e12213.

[111] Małys MS, Köller MC, Papp K, et al. Small extracellular vesicles are released ex vivo from platelets into serum and from residual blood cells into stored plasma. J Extracell Biol. 2023; 2(5): e88.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.